Description: 
The Epstein-Barr Virus Antibodies test is designed to detect the Epstein–Barr virus (EBV), also called human herpesvirus 4 (HHV-4), which is of the herpes family, and is one of the most common viruses in humans.


The Epstein-Barr virus is best known as the cause of infectious mononucleosis (glandular fever). However, it s also associate with particular forms of cancer, such as Hodgkin’s lymphoma, Burkitt’s lymphoma, nasopharyngeal carcinoma, and central nervous system lymphomas, associated with HIV.


Antibodies test:
After a person is infected with Borrelia burgdorferi, the bacterium that causes most cases of Lyme disease, their immune system will recognize the infection and react by producing antibodies against the bacterium. This is usually a two-step process. IgM antibodies are the first wave of attack. They appear within 3-4 weeks after initial infection and hit peak concentrations in about 6-8 weeks. IgM antibodies can persist for several months before they are no longer detectable.


The second phase of response is the production of IgG antibodies. They appear 6-8 weeks after infection and hit their peak concentrations at 4-6 months. Once infected, a person’s IgG level may remain detectable for the rest of his/her life. The spirochetes are tissue-loving organisms; therefore, their presence is transient in blood and other body fluids. One of the most important factors in laboratory tests for Lyme disease is timing the collection of the samples. If you obtain the sample too early or the patient doesn’t have a strong enough immune response, you may get a false negative test result.
Tests for:
The Epstein-Barr Virus (EBV) or human herpes virus 4 (HHV4)
 
Symptoms and conditions:
  • Potential higher risk of certain autoimmune diseases
  • Dermatomyositis (inflammation of muscles and skin)
  • Systemic Lupus erythematosus (autoimmune diseases)
  • Rheumatoid arthritis
  • Multiple sclerosis.
  • Infectious mononucleosis (glandular fever)
  • Hodgkin’s lymphoma
  • Burkitt’s lymphoma
  • Nasopharyngeal carcinoma
  • Central nervous system lymphomas
 
Method:
IgG Antibodies

​